1 / 32

INFLAMMATORY BOWEL DISEASE

INFLAMMATORY BOWEL DISEASE. Anusha Reddy FY1 SWFT 3 rd Feb 2014. objectives. 2 Case Studies: Crohn’s Vs Colitis THINK: AETIOLOGY EPIDEMIOLOGY SIGNS AND SYMPTOMS INVESTIGATIONS MANAGEMENT. Case Study 1. 22 Female PC: 6/52 of 5 x loose, non-bloody stools daily

stacia
Download Presentation

INFLAMMATORY BOWEL DISEASE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. INFLAMMATORY BOWEL DISEASE Anusha Reddy FY1 SWFT 3rd Feb 2014

  2. objectives • 2 Case Studies: Crohn’s Vs Colitis • THINK: • AETIOLOGY • EPIDEMIOLOGY • SIGNS AND SYMPTOMS • INVESTIGATIONS • MANAGEMENT

  3. Case Study 1 • 22 Female • PC: 6/52 of 5 x loose, non-bloody stools daily • Right lower quadrant abdominal pain (especially after eating) • 8kg weight loss • Bilateral knee and ankle pains

  4. More information required • Full history • Nil PMH, no hx of foreign travel • No medications or allergies • Current smoker- 5 pack-years • Examination • Definite and moderately tender 5-cm mass in the right lower quadrant • No joint effusion or skin lesions are noted

  5. Differential diagnosis • Gastroenteritis • Crohn’s Disease • Ulcerative Colitis • Irritable Bowel Syndrome • Behcet’s Disease • Bowel Cancer • Tuberculosis • Amyloidosis • Acute Appendicitis

  6. WHAT DO WE THINK THIS IS? • 22 Female • PC: 6/52 of 5 x loose, non-bloody stools daily • Right lower quadrant abdominal pain (especially after eating) • 8kg weight loss • Bilateral knee and ankle pains

  7. Crohn’s Disease- Definition • Chronic Inflammatory Bowel Disease (IBD) • Unknown Aetiology • Characterised by • Focal • Asymmetrical • Transmural • Occasionally granulomatous inflammation • Any part of the GI tract- mouth anus

  8. Crohn’s Disease- Epidemiology • Incidence: 9.56 per 100,0001 • Prevalence: 115,000 in the UK • Age of onset: 2 peaks 1) 15-30 Y (more common) 2) 60-80 Y • Female: Male 1.8:1 Children this is reversed! • Risk Factors2 • Mycobacterium paratuberculosis, Pseudomonas spp. & Listeria spp. • ↑TNF-alpha • High-fat diets • Genetic mutations 1) Steed H, Walsh S, Reynolds N; Crohn's disease incidence in NHS Tayside. Scott Med J. 2010 Aug;55(3):22-5 2) Rangasamy P et al; Crohn Disease, Medscape, Jun 2011

  9. Crohn’s Disease- Symptoms • Abdominal pain, cramping or swelling • Anaemia • Fever • Gastrointestinal bleeding • Joint pain • Malabsorption • Persistent or recurrent diarrhoea • Stomach ulcers • Vomiting • Weight loss

  10. Crohn’s Disease- On Examination • General ill health- weight loss & dehydrated • Hypotension, tachycardia and pyrexia • Abdominal tenderness or distension, palpable masses. • Anal and perianal lesions (abscesses, fistulae) • Mouth Ulcers • Extra-intestinal manifestations of Crohn’s ......

  11. Crohn’s Disease- Extra Intestinal

  12. Investigations • Bloods • FBC, CRP, U&Es, LFTs • Stool culture and microscopy • anti-S. cerevisiae antibodies Perinuclear antineutrophil cytoplasmic antibody (p-ANCA) (UC>CD) • Abdo Xray • Ileocolonscopy and biopsy from the terminal ileum as well as the affected sites • Small bowel follow through • If upper GI symptoms- Upper GI endoscopy • If lower GI symptoms- Flexible sigmoidoscopy/EUA

  13. Crohn’s Disease- Management • First presentation (NICE guidelines) • Glucocorticoids • Prednisolone, Methylprednisolone IV hydrocortisone • Budesonide • 5-ASA • +/- ADD ON Azathioprine or Mercaptopurine • Biologic: Infliximab and Adalimumab

  14. Crohn’s Disease- Management • Maintaining Remission (NICE guidelines) • Offer Azathioprine or Mercaptopurine as Monotherapy • Methotrixate • Surgery- if limited to distal ileum (weighing out the risk Vs benefits) and for complications...

  15. Crohn’s Disease- Complications B A C C

  16. Case Study 2 • 32 Male • Bloody diarrhoea 4/52 • Bilateral lower abdominal cramping • Malaise and weight loss • No associated fever, visual changes, arthralgias, or skin lesions • Previously fit and well contractor • Non-smoker, 14-18 units/week drinker • FHx: Diabetes Mellitus Type 1

  17. Ulcerative Colitis- Definition • Chronic Inflammatory Bowel Disease • Unknown aetiology • Only Large Colon • Classification: • Distal Disease • More extensive disease • Pancolitis

  18. Ulcerative Colitis- Epidemiology • More common than Crohn’s • Incidence: 10 per 100,000 • Prevalence 240 per 100,000 in the UK • Age of onset: 2 peaks 1) 15-25 Y (more common) 2) 55-65 Y • Male:Female= 1:1 • Idiopathic: ?autoimmune condition triggered by colonic bacteria  inflammation • Genetic component: sibling of an individual who has IBD 17-35 x more risk of development • Risk of UC decreased in smokers 1) Ulcerative Colitis; NICE Clinical Guideline (Jun 2013)

  19. Ulcerative Colitis- Symptoms • Bloody diarrhoea • Abdominal Pain • Tenesmus • Systemic symptoms: malaise, fever, weightless

  20. Ulcerative Colitis- On examination • Unwell, pale, febrile, dehydrated • Abdo pain and tenderness .. + distension • TOXIC MEGACOLON • Worrying signs: Tachycardia, anaemia and fever • Extra- intestinal disease...

  21. Ulcerative Colitis- Extra-intestinal • Aphthous ulcers • Ocular manifestations 5% • Episcleritis • Anterior uveitis • Acute arthropathy affecting the large joints 26% • Sacroiliitis • Ankylosing Spondylitis 3% • Deramatology 19% • Pyoderma gangrenosum • Erythema nodosum • Primary Sclerosing Cholangitis

  22. Ulcerative Colitis- Investigations • Bloods: FBC, LFTs, U+Es, CRP • Serology- pANCA Vs. ASCA • Stool cultures • Imaging • Abdo x-ray- acute setting • Barium enema- can show mucosal structure • Flexible Sigmoidoscopy and Biopsy- for diagnosis

  23. Ulcerative Colitis- Management a) Topical aminosalicylate alone (suppository or enema b) ?ADD PO aminosalicylate to a topical aminosalicylate OR c) consider an PO aminosalicylate alone a) PO Aminosalicylate - High induction dose of an b) ?ADD topical Aminosalicylate ORPO beclometasone dipropionate • If no improvement 72 hrs despite IV Hydrocortisone OR • Symptoms worsen to pancolitis: • a) ADD IV Ciclosporin to IV steroids

  24. Ulcerative Colitis- Management • Indications for Surgery: • Unresponsive to medical treatment • Significantly affecting quality of life • Growth retardation in Children • Life-threatening complications... • Bleeding • Toxic Megacolon • Impending perforation • Carcinoma

  25. Any Questions?

  26. SUMMARY

  27. Summary: Crohn’s Vs. UC (1)

  28. SUMMARY: Crohn’s Vs. UC (2)

  29. SUMMARY- Crohn’s Vs. UC (3)

  30. SUMMARY: Crohn’s Vs. UC (2)

  31. LEARNING POINTS • RELAPSE AND REMITTING MANAGE THE PATIENT • BONE PROTECTION- IF ON LONG-TERM STROIDS • TEST FOR TB BEFORE STARTING INFLIXIMAB • RISK OF COLONIC CARCINIMA IN UC

  32. THANK YOU!!

More Related